This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Criteria used to ensure the validity of primary studies
Not stated.
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Fifteen primary studies provided clinical data.
Methods of combining primary studies
The primary estimates were combined using weighted averages based on the number of patients participating in each study.
Investigation of differences between primary studies
Results of the review
The diagnostic yield was 69.59% with WCE, 53.87% with traditional work-up (average value of 59.14% with SBFT and 47.85% with COL), and 36.17% with enteroclysis.
The rate of perforation with COL was 0.03%.
The rate of retention with WCE was 0.75%.
Measure of benefits used in the economic analysis
No summary benefit measure was used in the economic analysis. In effect, a cost-consequences analysis was performed.
Direct costs
The perspective of the study was that of the payer. The economic analysis considered only the costs of the diagnostic techniques, the treatment of complications (perforation due to COL and capsule retention), and other diagnostic tests. The unit costs were presented separately from the quantities of resources used. Most of the costs were estimated using average Medicare reimbursement rates, including professional and technical fees. The costs of other diagnostic tests were derived from a published study. Resource use was mainly based on published data. Discounting was not relevant since the costs were incurred during a short timeframe. The price year appears to have been 2002.
primary studies was not addressed, as the authors noted. The primary estimates were combined by calculating average values, weighted by the number of patients recruited in each study. Uncertainty surrounding the clinical inputs was investigated in the sensitivity analysis. The authors stated that a conservative estimate of the diagnostic yield of WCE was used.
Validity of estimate of measure of benefit
No summary benefit measure was used in the analysis because a cost-consequences analysis was conducted. Please refer to the comments in the 'Validity of estimate of measure of effectiveness' field (above).
Validity of estimate of costs
The costs included were consistent with the perspective adopted in the study, although they were restricted to direct medical costs. Extensive information on the unit costs and quantities of resources used was provided, which enhances the possibility of replicating the results of the study in other settings. The costs were treated deterministically, but the impact of variations in clinical probability values on the total costs was estimated in the sensitivity analysis. The source of the costs was given. The price year was reported, which aids reflation exercises to other time periods. The authors stated that cost-savings associated with WCE were likely to have been underestimated because some potential benefits associated with an earlier diagnosis of CD were not accounted for in the analysis.
Other issues
The authors did not make extensive comparisons of their findings with those from other studies. They also did not address the issue of the generalisability of the study results to other settings. Some sensitivity analyses were carried out, which enhance in part the external validity of the study. The analysis referred to patients with suspected CD and this was reflected in the authors' conclusions. The authors noted some limitations to the validity of their analysis, which have been highlighted already.
Implications of the study
The study results supported the use of WCE for the diagnostic work-up of patients with suspected CD.
Source of funding
Supported by a grant from Given Imaging Inc., Yoqneam, Israel.
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